Ontology highlight
ABSTRACT: Background
Atrial fibrillation (AF) is associated with a risk for cognitive impairment and dementia, which is more pronounced in patients with a history of clinical stroke. Anticoagulation use and efficacy impact long-term risk of dementia in AF patients in observational trials.Methods
The cognitive decline and dementia in patients with non-valvular atrial fibrillation (CAF) Trial was a randomized, prospective, open-label vanguard clinical study with blinded endpoint assessment involving patients with moderate- to high-risk (CHADS2 or CHA2DS2-Vasc scores of ≥2) non-valvular AF assigned to dabigatran etexilate or warfarin. The primary endpoint was incident dementia or moderate cognitive decline at 24 months.Results
A total of 101 patients were enrolled [mean age:73.7
SUBMITTER: Bunch TJ
PROVIDER: S-EPMC9745454 | biostudies-literature | 2022 Dec
REPOSITORIES: biostudies-literature